Strong execution of a robust, valuation-aware approach makes this an attractive offering.
Boston Partners All Cap Value Inv BPAVX
- NAV / 1-Day Return 30.90 / −1.25 %
- Total Assets 1.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.050%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.22%
- Turnover 33%
USD | NAV as of Apr 30, 2024 | 1-Day Return as of Apr 30, 2024, 10:13 PM GMT+0
Morningstar’s Analysis BPAVX
Will BPAVX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Johnson & Johnson | 2.19 | 31.7 Mil | Healthcare |
JPMorgan Chase & Co | 2.00 | 28.9 Mil | Financial Services |
CRH PLC | 1.97 | 28.5 Mil | Basic Materials |
AbbVie Inc | 1.97 | 28.5 Mil | Healthcare |
Alphabet Inc Class A | 1.90 | 27.4 Mil | Communication Services |
Booking Holdings Inc | 1.79 | 25.9 Mil | Consumer Cyclical |
Check Point Software Technologies Ltd | 1.78 | 25.7 Mil | Technology |
Bristol-Myers Squibb Co | 1.74 | 25.2 Mil | Healthcare |
American International Group Inc | 1.68 | 24.3 Mil | Financial Services |
Corpay Inc | 1.62 | 23.5 Mil | — |